Loading stock data…
$5.02-0.07 (-1.38%)
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Journey Medical Corporation in the Healthcare sector is trading at $5.02 with a market capitalization of $208M. Wall Street consensus targets $13.75 (4 analysts), implying a +173.9% move over the next 12 months. The stock is currently near its 52-week low of $4.31, remaining 25.1% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 26 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $18.51M↑ | $15.96M↓ | $16.08M↓ | $17.63M↑ | $15.01M |
| Gross Profit | $12.37M↑ | $9.74M↓ | $10.64M↓ | $11.88M↑ | $10.07M |
| Operating Income | $456,000↑ | -$1.49M↓ | -$443,000↑ | -$1.53M↑ | -$2.88M |
| Net Income | -$312,000↑ | -$2.23M↓ | -$1.25M↑ | -$2.31M↑ | -$3.80M |
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed produc...